Literature DB >> 25056968

Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells.

Pablo F Céspedes1, Susan M Bueno1, Bruno A Ramírez1, Roberto S Gomez2, Sebastián A Riquelme2, Christian E Palavecino1, Juan Pablo Mackern-Oberti1, Jorge E Mora1, David Depoil3, Catarina Sacristán4, Michael Cammer4, Alison Creneguy5, Tuan H Nguyen5, Claudia A Riedel6, Michael L Dustin3, Alexis M Kalergis7.   

Abstract

Human respiratory syncytial virus (hRSV) is the leading cause of bronchiolitis and pneumonia in young children worldwide. The recurrent hRSV outbreaks and reinfections are the cause of a significant public health burden and associate with an inefficient antiviral immunity, even after disease resolution. Although several mouse- and human cell-based studies have shown that hRSV infection prevents naïve T-cell activation by antigen-presenting cells, the mechanism underlying such inhibition remains unknown. Here, we show that the hRSV nucleoprotein (N) could be at least partially responsible for inhibiting T-cell activation during infection by this virus. Early after infection, the N protein was expressed on the surface of epithelial and dendritic cells, after interacting with trans-Golgi and lysosomal compartments. Further, experiments on supported lipid bilayers loaded with peptide-MHC (pMHC) complexes showed that surface-anchored N protein prevented immunological synapse assembly by naive CD4(+) T cells and, to a lesser extent, by antigen-experienced T-cell blasts. Synapse assembly inhibition was in part due to reduced T-cell receptor (TCR) signaling and pMHC clustering at the T-cell-bilayer interface, suggesting that N protein interferes with pMHC-TCR interactions. Moreover, N protein colocalized with the TCR independently of pMHC, consistent with a possible interaction with TCR complex components. Based on these data, we conclude that hRSV N protein expression at the surface of infected cells inhibits T-cell activation. Our study defines this protein as a major virulence factor that contributes to impairing acquired immunity and enhances susceptibility to reinfection by hRSV.

Entities:  

Keywords:  T lymphocyte priming; cSMAC; nucleocapsid protein; pSMAC

Mesh:

Substances:

Year:  2014        PMID: 25056968      PMCID: PMC4128097          DOI: 10.1073/pnas.1400760111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

1.  Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch.

Authors:  Patrick M Gubser; Glenn R Bantug; Leyla Razik; Marco Fischer; Sarah Dimeloe; Gideon Hoenger; Bojana Durovic; Annaïse Jauch; Christoph Hess
Journal:  Nat Immunol       Date:  2013-08-18       Impact factor: 25.606

2.  Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies.

Authors:  Roberto S Gómez; Jorge E Mora; Claudia M Cortés; Claudia A Riedel; Marcela Ferrés; Susan M Bueno; Alexis M Kalergis
Journal:  J Med Virol       Date:  2013-10-22       Impact factor: 2.327

3.  Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

Authors:  L K Hallak; D Spillmann; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

6.  Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

Authors:  C R Bangham; P J Openshaw; L A Ball; A M King; G W Wertz; B A Askonas
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

7.  Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains.

Authors:  Marietjie Venter; Michael Rock; Adrian J Puren; Caroline T Tiemessen; James E Crowe
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production.

Authors:  K Ravanel; C Castelle; T Defrance; T F Wild; D Charron; V Lotteau; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

9.  Rapid effector function in CD8+ memory T cells.

Authors:  A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Biophysical mechanism of T-cell receptor triggering in a reconstituted system.

Authors:  John R James; Ronald D Vale
Journal:  Nature       Date:  2012-07-05       Impact factor: 49.962

View more
  33 in total

1.  CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection.

Authors:  Rebecca A Elsner; Christine J Hastey; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

Review 2.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 3.  A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.

Authors:  Emma Rey-Jurado; Jorge Soto; Nicolás Gálvez; Alexis M Kalergis
Journal:  Hum Vaccin Immunother       Date:  2017-06-09       Impact factor: 3.452

4.  Enzymatic Insertion of Lipids Increases Membrane Tension for Inhibiting Drug Resistant Cancer Cells.

Authors:  Jiaqing Wang; Weiyi Tan; Guanying Li; Difei Wu; Hongjian He; Jiashu Xu; Meihui Yi; Ye Zhang; S Ali Aghvami; Seth Fraden; Bing Xu
Journal:  Chemistry       Date:  2020-10-15       Impact factor: 5.236

Review 5.  Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.

Authors:  Andrea E González; Margarita K Lay; Evelyn L Jara; Janyra A Espinoza; Roberto S Gómez; Jorge Soto; Claudia A Rivera; Katia Abarca; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Virulence       Date:  2016-12-02       Impact factor: 5.882

6.  Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.

Authors:  Roberto S Gómez; Bruno A Ramirez; Pablo F Céspedes; Kelly M Cautivo; Sebastián A Riquelme; Carolina E Prado; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2015-11-06       Impact factor: 7.397

7.  HIV Envelope gp120 Alters T Cell Receptor Mobilization in the Immunological Synapse of Uninfected CD4 T Cells and Augments T Cell Activation.

Authors:  Jing Deng; Yu-Ya Mitsuki; Guomiao Shen; Jocelyn C Ray; Claudia Cicala; James Arthos; Michael L Dustin; Catarina E Hioe
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 8.  Modulation of the host immune response by respiratory syncytial virus proteins.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 2.902

Review 9.  Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases.

Authors:  Nicolás M S Gálvez; Karen Bohmwald; Gaspar A Pacheco; Catalina A Andrade; Leandro J Carreño; Alexis M Kalergis
Journal:  Clin Microbiol Rev       Date:  2020-12-23       Impact factor: 26.132

Review 10.  Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.

Authors:  Gisela Canedo-Marroquín; Orlando Acevedo-Acevedo; Emma Rey-Jurado; Juan M Saavedra; Margarita K Lay; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2017-08-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.